The Bill and Melinda Gates Foundation has allocated $ 750 million to produce and distribute a vaccine for COVID-19 developed by the University of Oxford.
The money comes from a deal with the British-Swedish pharmaceutical company AstraZeneca, η οποία συνεργάζεται με οργανώσεις που αγωνίζονται για την προστασία του κόσμου από μολυσματικές ασθένειες όπως τον COVID-19: Serum Institute of India (SII), Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi Vaccine Alliance (Gavi), the latter two of which are directly funded by Gates.
The Gates millions will support her delivery 300 million doses of a vaccine called AZD1222. The first shipments are expected to begin by the end of 2020.
A separate licensing agreement with SII will provide one billion installments to low- and middle-income countries, with 400 million to be disbursed before 2021.
This move is in line with Gates' strategy for the rapid development of a vaccine COVID-19: "Develop seven vaccines at once and hopefully one of them will work - even if billions of dollars are wasted."
Indeed, there is currently no guarantee that AZD1222 will prove effective. The first indication will come in August, the earliest.
However, the University of Oxford is beginning trials in Phases II / III of AZD1222 with approximately 10.000 adult volunteers. AstraZeneca said that final testing will begin in some countries.
"AstraZeneca recognizes that the vaccine may not work but is committed to advancing the clinical program rapidly and increasing production," the company said.
Gates on the other hand finally expressed his frustration with a persistent theory conspiracy that wants its co-founder Microsoft to monitor the human race implanting them microchips with COVID-19 vaccines.